Medical Xpress October 18, 2024
Colin Poitras, Yale University

Expanding access to new, highly effective weight-loss medications could prevent more than 40,000 deaths a year in the United States, according to a new study led by researchers at Yale School of Public Health and the University of Florida.

The work is published in the journal Proceedings of the National Academy of Sciences.

The findings highlight the critical need to remove existing barriers that are hindering people’s access to effective weight-loss treatments and impeding public health efforts to address the national obesity crisis, the researchers said. According to the U.S. Centers for Disease Control and Prevention, about 74% of Americans are considered overweight, with about 43% of those individuals considered obese.

Obesity’s widespread impact on health is well-documented. It exacerbates...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Provider, Survey / Study, Trends
More than half of US adults could benefit from GLP-1 medications, researchers find
Data show 24.3% of U.S. adults had chronic pain in past three months in 2023
GLP-1 drug coverage for obesity making inroads with large employers: Mercer
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Advocate Health takes to Capitol Hill on hospital at home: 5 notes

Share This Article